BX Swiss TOP 30 CHF
1.228,04
PKT
-12,73
PKT
-1,03
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
20.10.17 | Roche Hold | Kepler Cheuvreux | |
20.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.10.17 | Nestlé buy | Goldman Sachs Group Inc. | |
20.10.17 | Swiss Re overweight | JP Morgan Chase & Co. | |
20.10.17 | Nestlé buy | Baader Bank | |
20.10.17 | Roche Reduce | HSBC | |
19.10.17 | Roche Neutral | UBS AG | |
19.10.17 | Roche Hold | Baader Bank | |
19.10.17 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
19.10.17 | Nestlé buy | Baader Bank | |
19.10.17 | Nestlé buy | UBS AG | |
19.10.17 | Roche overweight | JP Morgan Chase & Co. | |
19.10.17 | Nestlé overweight | JP Morgan Chase & Co. | |
18.10.17 | Roche Neutral | Citigroup Corp. | |
18.10.17 | Holcim Neutral | JP Morgan Chase & Co. | |
17.10.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
17.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
17.10.17 | ABB (Asea Brown Boveri) Neutral | Goldman Sachs Group Inc. | |
17.10.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
16.10.17 | Holcim Neutral | UBS AG | |
16.10.17 | Roche overweight | JP Morgan Chase & Co. | |
16.10.17 | Roche buy | Jefferies & Company Inc. | |
16.10.17 | Novartis buy | Jefferies & Company Inc. | |
16.10.17 | Roche Neutral | Credit Suisse Group | |
13.10.17 | Givaudan Neutral | BNP PARIBAS | |
12.10.17 | Holcim Neutral | BNP PARIBAS | |
12.10.17 | Novartis buy | HSBC | |
12.10.17 | UBS buy | HSBC | |
12.10.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
11.10.17 | Nestlé overweight | Morgan Stanley | |
11.10.17 | Swiss Re Neutral | BNP PARIBAS | |
11.10.17 | Swiss Re Neutral | BNP PARIBAS | |
11.10.17 | ABB (Asea Brown Boveri) Hold | HSBC | |
11.10.17 | Givaudan overweight | JP Morgan Chase & Co. | |
11.10.17 | Givaudan Neutral | Goldman Sachs Group Inc. | |
10.10.17 | Swiss Re Sell | UBS AG | |
10.10.17 | Givaudan Neutral | UBS AG | |
10.10.17 | Novartis Neutral | JP Morgan Chase & Co. | |
10.10.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG |